Drugs / Floseal
Floseal
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT01974193 | Dec 2013 → Dec 2015 | female reproductive organ cancer | Ewha Womans University Mokdong Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT01407263 | Jul 2011 → Jul 2026 overdue | prostate cancer | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT01891461 | Jan 2012 → Jan 2017 | — | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | Completed | No outcome recorded |
| Phase 4 | NCT01410240 | Sep 2011 → Jan 2013 | osteoarthritis | Baxter Healthcare Corporation | Completed | No outcome recorded |
| Phase 4 | NCT00742313 | Jun 2009 → Sep 2012 | hemorrhagic disease | Duke University | Terminated | No outcome recorded |
| Phase 4 | NCT00990288 | Oct 2007 → Aug 2010 | — | Hospital for Special Surgery, New York | Completed | No outcome recorded |
| Phase not applicable3 trials | ||||||
| — | NCT02638012 | Dec 2015 → Oct 2019 | hereditary hemorrhagic telangiectasia | Unity Health Toronto | Completed | No outcome recorded |
| — | NCT01679483 | Sep 2012 → Nov 2015 | cervical cancer, endometrial cancer, fallopian tube cancer, ovarian cancer | Asan Medical Center | Completed | No outcome recorded |
| — | NCT01098578 | Apr 2010 → Nov 2011 | — | Ottawa Hospital Research Institute | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03623789 Comparator | Aug 2018 → Jul 2020 | — | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT03328832 Comparator | Sep 2017 → Sep 2018 | osteoarthritis, knee | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02865174 Comparator | Sep 2016 → Aug 2017 | osteoarthritis, knee | Chang Gung Memorial Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02152917 Comparator | Feb 2014 → Feb 2015 | osteoarthritis, knee | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLOSEAL | “the operating surgeon may choose to use either Surgicel™, Surgicel SNoW™, Arista™, FloSeal or surgeon's choice HA” NCT01407263 ↗ |
| Known as | Floseal hemostatic matrix | “Floseal hemostatic matrix” NCT02638012 ↗ |
| Known as | FloSeal Matrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00742313 ↗ |
| Modality | Other / unclassified | “Floseal, a hemostatic agent” NCT01098578 ↗ |
| Route | Topical | “Topical Hemostatic Agent” NCT00990288 ↗ |